Price$27.90-0.40 (-1.41%)
02:30 PM07:45 PM
News · 26 weeks57-53%
2025-12-072026-05-31
Mix2890d
- Insider13(46%)
- SEC Filings8(29%)
- Other3(11%)
- Earnings2(7%)
- Analyst2(7%)
Latest news
25 items- ANALYSTCanaccord Genuity initiated coverage on Claritev with a new price targetCanaccord Genuity initiated coverage of Claritev with a rating of Buy and set a new price target of $32.00
- INSIDEREVP, Chief Digital Officer Kim Michael bought $49,950 worth of shares (3,000 units at $16.65), increasing direct ownership by 2% to 185,878 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERDirector Prince John Michael bought $160,000 worth of shares (10,000 units at $16.00), increasing direct ownership by 46% to 31,662 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERPres., CEO & Executive Chair Dalton Travis bought $258,638 worth of shares (20,920 units at $12.36) (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- SECClaritev Corporation filed SEC Form 8-K: Regulation FD Disclosure8-K - Claritev Corp (0001793229) (Filer)
- PRClaritev Launches PHCS Novera to Give TPAs More Control Over Network Design Amid Rising Healthcare CostsNew Primary Network Solution Helps Balance Regional Access, National Reach, and Cost Discipline As healthcare costs accelerate and employers demand more control over network strategy, Claritev Corporation (NYSE:CTEV), a healthcare technology, data and insights company, today announced the launch of PHCS Novera, a primary network solution designed to help deliver flexible, competitive options. With nearly two-thirds of covered workers enrolled in self-funded insurance plans and healthcare costs projected to rise 9.5% in 2026, employers are increasingly pushing third-party administrators (TPAs) to deliver more flexible, cost-conscious network designs. PHCS Novera was built to meet that de
- PRClaritev Corporation Announces Participation in BofA Securities Global Health Care Conference 2026Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will meet with investors and host a presentation at the BofA Securities 2026 Global Health Care Conference in Las Vegas. The Company will webcast its presentation scheduled for 5:00 pm PT on Wednesday, May 13, 2026. To listen to the webcast, please visit https://investors.claritev.com/events-and-presentations/. For one-on-one meetings, please contact a representative at the host firm. About Claritev Claritev is a healthcare technology, data, and insights co
- SECSEC Form S-8 filed by Claritev CorporationS-8 - Claritev Corp (0001793229) (Filer)
- SECSEC Form 10-Q filed by Claritev Corporation10-Q - Claritev Corp (0001793229) (Filer)
- SECClaritev Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Claritev Corp (0001793229) (Filer)
- PRClaritev Corporation Reports First Quarter 2026 ResultsQ1 2026 Revenues of $244.7 million grew 5.8% compared to Q1 2025 Net Loss of $73.6 million Adjusted EBITDA of $146.9 million increased 3.4% compared to Q1 2025 (Adjusted EBITDA Margin of 60.0% versus 61.4% in Q1 2025) Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2026. "Claritev kicked off 2026 the same way we closed 2025, outperforming on the top and bottom lines with focused execution in sales, operations and financials. We are operating with confidence — confidence in our te
- INSIDERDirector Klapstein Julie D was granted 8,977 shares, increasing direct ownership by 57% to 24,611 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERDirector Klein Michael Stuart was granted 8,977 shares, increasing direct ownership by 58% to 24,334 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERDirector Harris C Martin was granted 8,977 shares, increasing direct ownership by 59% to 24,282 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERDirector Kap Jason Lamar was granted 8,977 shares, increasing direct ownership by 122% to 16,333 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERDirector Clarke Richard A was granted 8,977 shares, increasing direct ownership by 58% to 24,334 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERDirector Prince John Michael was granted 8,977 shares, increasing direct ownership by 71% to 21,662 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERDirector Colaluca Anthony Jr was granted 8,977 shares, increasing direct ownership by 58% to 24,334 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- SECClaritev Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Claritev Corp (0001793229) (Filer)
- PRClaritev Chief AI Officer Fernando Schwartz Named to DataIQ 100 for Advancing AI-Driven Healthcare PerformanceRecognition highlights Claritev's progress embedding AI into healthcare workflows to reduce cost, improve performance, and increase transparency Claritev, a healthcare technology, data, and insights company, today announced that Fernando Schwartz, Ph.D., Senior Vice President and Chief AI Officer, has been named to the DataIQ 100 North America list for 2026, recognizing leaders applying data and artificial intelligence to drive measurable impact across industries. The recognition reflects Claritev's progress in embedding AI into healthcare workflows to help reduce administrative complexity, improve financial performance, and support informed decision-making across the healthcare ecosyst
- ANALYSTBarclays initiated coverage on Claritev with a new price targetBarclays initiated coverage of Claritev with a rating of Overweight and set a new price target of $28.00
- PRClaritev Corporation Announces First Quarter 2026 Earnings Conference CallClaritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its first quarter fiscal year 2026 financial results prior to market open on Thursday, May 7, 2026, and hold a conference call at 8:00 am Eastern Time. A live webcast of the conference call can be accessed through the Investor Relations section of the Company's website at investors.claritev.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. The earnings press release and supplemental slide deck
- INSIDERSEC Form 4 filed by Albinson Brock4 - Claritev Corp (0001793229) (Issuer)
- SECSEC Form DEFA14A filed by Claritev CorporationDEFA14A - Claritev Corp (0001793229) (Filer)
- SECSEC Form DEF 14A filed by Claritev CorporationDEF 14A - Claritev Corp (0001793229) (Filer)
CTEV FAQ
6 questionsWhere does CTEV stock trade?
Claritev Corporation (CTEV) is listed on NYSE.What sector and industry is CTEV in?
Claritev Corporation operates in the Real Estate sector.When did Claritev Corporation go public?
Claritev Corporation (CTEV) completed its IPO in 2020.What are analysts saying about CTEV?
Claritev Corporation has had 6 recent analyst actions on file. The most recent action was from Canaccord Genuity: Buy with a $3200.00 price target on 2026-05-29. Recent price targets range from $2800.00 to $4400.00.What companies are similar to CTEV?
Notable peers in the same industry include V (Visa Inc.), MA (Mastercard Incorporated), BABA (Alibaba Group Holding Limited), UBER (Uber Technologies Inc.), ACN (Accenture plc). Compare CTEV side-by-side with any of them on Quantisnow.How can I track CTEV on Quantisnow?
Quantisnow aggregates Claritev Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CTEV to receive live email and push alerts on every new disclosure.